CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-01 | Cook Jennifer E. Director | Option exercise | +3,253 | 3,253 | ||
| 2021-06-01 | Cook Jennifer E. Director | Option exercise · Restricted Stock Units | −3,253 | 0 | ||
| 2021-06-01 | Cole Douglas G. Director | Option exercise | +3,253 | 3,253 | ||
| 2021-06-01 | Cole Douglas G. Director | Option exercise · Restricted Stock Units | −3,253 | 0 | ||
| 2021-06-01 | Watts Ryan J. President and CEO | Sale | −13,127 | $60.98 | $801K | 2,215,948 |
| 2021-06-01 | Watts Ryan J. President and CEO | Sale | −2,750 | $62.09 | $171K | 2,213,198 |
| 2021-06-01 | Watts Ryan J. President and CEO | Sale | −2,102 | $62.76 | $132K | 2,211,096 |
| 2021-06-01 | Watts Ryan J. President and CEO | Sale | −354 | $63.50 | $22K | 2,210,742 |
| 2021-05-26 | SATO VICKI L Director | Sale | −894 | $64.90 | $58K | 134,861 |
| 2021-05-26 | SATO VICKI L Director | Sale | −732 | $65.88 | $48K | 134,129 |
| 2021-05-26 | SATO VICKI L Director | Sale | −40 | $66.72 | $3K | 134,089 |
| 2021-05-24 | Tessier-Lavigne Marc Director | Sale | −8,806 | $60.03 | $529K | 2,542,296 |
| 2021-05-21 | Tessier-Lavigne Marc Director | Sale | −37,957 | $60.13 | $2.3M | 2,551,102 |
| 2021-05-12 | NELSEN ROBERT Director | Other disposition | −500,000 | 9,668,749 | ||
| 2021-05-12 | NELSEN ROBERT Director | Other acquisition | +2,537 | 7,105 | ||
| 2021-05-04 | Schuth Alexander O. COO and Secretary | Sale | −5,998 | $55.09 | $330K | 515,584 |
| 2021-05-04 | Schuth Alexander O. COO and Secretary | Sale | −3,557 | $55.92 | $199K | 512,027 |
| 2021-05-04 | Schuth Alexander O. COO and Secretary | Sale | −445 | $57.39 | $26K | 511,582 |
| 2021-05-03 | Tessier-Lavigne Marc Director | Sale | −3,139 | $60.08 | $189K | 2,589,157 |
| 2021-05-03 | Tessier-Lavigne Marc Director | Sale | −98 | $61.20 | $6K | 2,589,059 |
Page 23 of 53 · 1,053 trades